MADRID — Chemotherapy’s generation-long dominance in first-line advanced urothelial cancer ended with a resounding victory for the antibody-drug conjugate (ADC) enfortumab ve… Read More
MADRID — Including pembrolizumab (Keytruda) in the first-line treatment of metastatic HER2-positive gastric or gastroesophageal cancer improved progression-free survival (PFS), but… Read More
At the outset, cancer vaccines were plagued with false starts and modest success at best. But they now represent a promising therapeutic strategy in the immunotherapy of solid tumors.
&ldq… Read More
If the integration of natural sciences and engineering sciences interests you, a Master’s in Biotechnology in the UK is the path for you. It offers a deep dive into the study of biote… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myelofibrosis pipeline constitutes 45+ key companies continuously working towards developing 45+ Myelof… Read More
Lupus Nephritis Market was worth USD 1.9 Billion in 2022, is estimated to grow at a CAGR of 6.8% in the forecasted period. The forecasted revenue hints at a growth of around 3.32 billio… Read More
Mia Hamm is an athlete to her core. While the two-time Olympic gold medalist retired from soccer in 2004, it's clear that she still takes any athletic competition very seriously.
As the two… Read More
Maintenance therapy with cetuximab (Erbitux) after FOLFIRI (leucovorin, fluorouracil, and irinotecan) plus cetuximab induction therapy led to better outcomes for patients with RAS wild-typ… Read More
The B-Cell Lymphoma Pipeline Insight 2023 report by DelveInsight offers a thorough global overview of B-Cell Lymphoma treatments, including those already in the market, as well as those in… Read More
According to the report by Expert Market Research (EMR), the Global Graft Versus Host Disease Treatment Market Size is projected to grow at a CAGR of 8.50% between 2023 and 2028. A… Read More
(Albany, United States) As per DelveInsight’s assessment, globally, the Non-Muscle Invasive Bladder Cancer Pipeline constitutes 25+ key companies continuously working towards developi… Read More
Tinea Pedis Treatment Market | IndustryARC
Snowballing global temperature is Projected to Drive Tinea Pedis Treatment Market Growth
Tinea Pedis Treatment Market size is estimaed to reac… Read More
BAKER BROS. ADVISORS LP, a renowned hedge fund sponsor, recently made a significant investment in Mereo BioPharma Group PLC. This article provides an in-depth analysis of the transaction, th… Read More
Exposure to outdoor air pollution may increase the risk of several non-lung cancers. (Harvard T. H. Chan School of Public Health, Environmental Epidemiology)
A physician talks about the sh… Read More
Market Commentary
Global equities continued to appreciate in the second quarter, after performing strongly in the first quarter of 2023. During the first half of 2023, the MSCI ACWI Index… Read More
The immune checkpoint inhibitors market size is poised to grow by $ 148.1 billion by 2030 from $ 37.31 billion in 2022, exhibiting a CAGR of 18.81% during the forecast period 2022-2030. … Read More
Immunotherapy, which uses immune pathways to treat cancer, is rapidly becoming an accepted cancer treatment after surgery, chemotherapy and radiation. Checkpoint blocking using monoclonal an… Read More
Janus kinases (JAKs) belong to the non-receptor tyrosine kinase family, and their JAK-STAT signaling pathway with signal transducers and activators of transcription (STAT) can affect cell pr… Read More
CHICAGO — In patients with metastatic EGFR-positive lung cancer who progressed on targeted agents, adding pembrolizumab (Keytruda) to a standard chemotherapy regimen demonstrated n… Read More
The antibody-drug conjugate (ADC) inotuzumab ozogamicin (Besponsa) combined with low-intensity chemotherapy — with or without blinatumomab (Blincyto) — showed promise in ol… Read More
Incorporating quizartinib into standard treatment for newly diagnosed acute myeloid leukemia (AML) followed by maintenance therapy with the investigational FLT3 inhibitor improved survival… Read More
essential thrombocythemia bleeding :: Article CreatorA Clinical-molecular Prognostic Model To Predict Survival In Patients With Post Polycythemia Vera And Post Essen… Read More
"Thrombocythaemia Myelofibrosis Treatment Market Overview by Trends 2023-2030The Thrombocythaemia Myelofibrosis Treatment market report provides a comprehensive analysis of the global indust… Read More
The Multiple Myeloma market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Mul… Read More
RiverPark Advisors, an investment advisory firm, and sponsor of the RiverPark family of mutual funds released its “RiverPark Large Growth Fund” fourth quarter 2022 investor lette… Read More